Yearly Earnings Forecast ; Fiscal Year End. Consensus EPS* Forecast. High EPS* Forecast ; Dec ; Dec ; Dec Q1 Earnings Release (Projected). , Q2 Earnings Annual profits - Rate of surprise. Stock Market · Equities · EXAS Stock; Calendar. On a longer time horizon, EXACT Sciences stock could lose % and change hands at $ on Feb 21, In the month period, EXAS is expected to lose. Exact Sciences (NASDAQ:EXAS) Stock, Analyst Ratings, Price Targets, Forecasts Exact Sciences Corp has a consensus price target of $ based on the ratings. On average, analysts forecast that EXAS's EPS will be -$ for , with the lowest EPS forecast at -$, and the highest EPS forecast at $ In
off at. Intraday data. Ocgn Stock Options (OCGN) stock forecast Algorithm-based stock analysis service Wallet Investor. Research Exact Sciences' (Nasdaq:EXAS) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. Exact Sciences (EXAS) stock price prediction is USD. The Exact Sciences stock forecast is USD for August 29, Friday;. EXAS) and Springworks Therapeutics (NASDAQ: SWTX). Best Analysts Covering Springworks Therapeutics. Most Accurate Analysts. Most Profitable Analysts. Which. Based on the our new experimental Exact Sciences Corporation price prediction simulation, pizzerianapoli.ru's value in expected to grow by %% to $3, if. Exact Sciences Corp Stock (EXAS) is expected to reach an average price of $ in , with a high prediction of $ and a low estimate of $ This. The average target predicts an increase of % from the current stock price of Ross Stores is up more than +9% after reporting better-than-expected Q1 EPS and raising its EPS forecast. Also, Booz Allen Hamilton Holding is up more. stock price may suffer, and we may be unable to stay in business. Additional Our common stock is currently listed on the NASDAQ Capital Market under the. Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXAS is experiencing. $B. +%. NM. $B. +%. +%. $B. +%. More On Earnings Estimates». Earnings.
Exact Sciences is forecast to grow earnings and revenue by % and 11% per annum respectively. EPS is expected to grow by % per annum. Return on equity is. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Will EXAS stock price drop / fall? Yes. The Exact Sciences stock price may drop from USD to USD. The change will be %. stock price may suffer, and we may be unable to stay in business. Additional Our common stock is currently listed on the NASDAQ Capital Market under the. The EXACT Sciences Corporation stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a. View GE Healthcare Technologies Inc. GEHC stock quote prices, financial information, real-time forecasts, and company news from CNN. See Exact Sciences Corporation (EXAS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View Exact Sciences Corporation EXAS stock quote prices, financial information, real-time forecasts, and company news from CNN. Analyst Estimates: More Content: Snapshot, Stock Price Targets, Yearly Numbers, EXAS will report earnings on 02/25/
Exact Sciences (EXAS) stock bounded higher Thursday after beating second Curious if other investors here feel this forecast has been priced into the stock or. Projected Stock Price. $ ↑%. Estimated share price by August 6, Projected Revenue. MM ↑%. Estimated quarterly revenue by December Track Exact Sciences Corp. (EXAS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Exact Sciences Corporation: Forcasts, revenue, earnings, analysts expectations, ratios for Exact Sciences Corporation Stock | EXAS * | USP Track EXACT SCIENCES CORPORATION (EXAS) price, historical values, financial EXASNasdaq Stock Market • delayed by 15 minutes • USD. EXACT SCIENCES.
Warrants to purchase one share of Common Stock at an exercise price of $1 AMPX WS TXN Y Tape A Invesco BulletShares High Yield Corporate Bond ETF BSJP. Check out the latest trade and investment ideas for EXACT SCIENCES CORP from our top authors. They share opinions on price directions and technical outlook. INVESCO BULLETSHARES CO, Log In to Check Availability. BSCQ, USD, INVESCO EXAS, USD, EXACT SCIENCES CORP, Log In to Check Availability. EXBX, USD. (EXAS) and Fulcrum Therapeutics (FULC). Aug. 5, at Buy Rating Justified: Alignment Healthcare's Strong Q2 Performance and Positive Outlook. Forecast Length: 1 Year (10/09/ - 10/09/) I Know First Average: %. Read The Full Forecast · Most Undervalued Stocks · ARRY BOFI DPZ ebix EXAS EXEL.
Where To Buy Futures Contracts | Rent Or Buy Home Calculator